Alpha Thalassemia clinical trials at UCSF
1 research study open to new patients
open to all eligible people
The investigators aims to evaluate the safety of in utero hematopoietic stem cell transplantation in fetuses with alpha-thalassemia major performed at the time of in utero transfusion of red blood cells.
San Francisco, California
Last updated: October 5, 2017